isexufehub.wordpress.com
Genzyme (NASDAQ: GENZ) founc a virus strain and stoppe d production of two drugs atthe Allston, facility. The strain, Vesivirus 2117, apparently does not causer human infection but interrupts the growthn of cells that are used tomake drugs. Aldurazymw — a treatment for MPS I, a rare and fatal diseas e caused by an enzymedeficiencyy — was last filled at the Genzymde facility in September 2008, according to BioMarinm (NASDAQ: BMRN). The company has abouyt 10 months of vialex inventoryon hand, it said, and uses a seconcd fill finish supplier. A third supplier is expectedx to be qualified laterthis year, BioMarih said.
BioMarin makes the bulk material used in Aldurazymee at itsNovato facility. The Food and Drug Administrationn hadinspected Genzyme’s plant in September and October and reportedly was concerned about controla to protect against contamination.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment